LUPPI, Fabrizio
 Distribuzione geografica
Continente #
NA - Nord America 8.301
EU - Europa 6.960
AS - Asia 3.686
SA - Sud America 557
AF - Africa 70
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 7
Totale 19.591
Nazione #
US - Stati Uniti d'America 8.168
IT - Italia 3.752
SG - Singapore 1.298
GB - Regno Unito 1.233
CN - Cina 894
VN - Vietnam 432
BR - Brasile 418
SE - Svezia 409
HK - Hong Kong 375
DE - Germania 310
FR - Francia 283
FI - Finlandia 217
UA - Ucraina 193
RU - Federazione Russa 187
TR - Turchia 123
NL - Olanda 116
IN - India 111
KR - Corea 83
CA - Canada 69
BG - Bulgaria 63
ID - Indonesia 63
AR - Argentina 51
MX - Messico 47
BD - Bangladesh 46
IQ - Iraq 43
JP - Giappone 41
IE - Irlanda 33
BE - Belgio 31
ZA - Sudafrica 23
PL - Polonia 22
EC - Ecuador 20
ES - Italia 20
PK - Pakistan 20
VE - Venezuela 20
AE - Emirati Arabi Uniti 16
IR - Iran 15
SA - Arabia Saudita 14
CL - Cile 12
LT - Lituania 12
NP - Nepal 12
CH - Svizzera 11
MA - Marocco 11
MY - Malesia 11
CO - Colombia 10
PY - Paraguay 10
TW - Taiwan 10
AT - Austria 9
AU - Australia 9
TH - Thailandia 9
TN - Tunisia 9
JO - Giordania 8
PH - Filippine 8
AZ - Azerbaigian 7
HR - Croazia 7
KE - Kenya 7
LV - Lettonia 7
PE - Perù 7
EU - Europa 6
IL - Israele 6
LB - Libano 6
DK - Danimarca 5
DZ - Algeria 5
KZ - Kazakistan 5
NO - Norvegia 5
PT - Portogallo 5
BO - Bolivia 4
CY - Cipro 4
DO - Repubblica Dominicana 4
RO - Romania 4
RS - Serbia 4
SY - Repubblica araba siriana 4
UY - Uruguay 4
UZ - Uzbekistan 4
BZ - Belize 3
CZ - Repubblica Ceca 3
EE - Estonia 3
EG - Egitto 3
ET - Etiopia 3
PR - Porto Rico 3
SI - Slovenia 3
BH - Bahrain 2
BY - Bielorussia 2
GA - Gabon 2
GE - Georgia 2
GR - Grecia 2
HU - Ungheria 2
KG - Kirghizistan 2
KW - Kuwait 2
LU - Lussemburgo 2
MN - Mongolia 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
QA - Qatar 2
SN - Senegal 2
AL - Albania 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CG - Congo 1
CV - Capo Verde 1
Totale 19.576
Città #
Southend 887
Singapore 857
Ashburn 811
Fairfield 792
Santa Clara 735
Chandler 478
Woodbridge 476
Houston 397
Hong Kong 365
San Jose 313
Ann Arbor 308
Seattle 273
Wilmington 265
Rome 261
Jacksonville 250
Milan 249
Cambridge 244
Dearborn 233
Nyköping 222
Beijing 201
London 163
Helsinki 162
Hefei 155
Modena 152
Ho Chi Minh City 121
New York 121
Los Angeles 115
Council Bluffs 114
Hanoi 109
Chicago 103
San Diego 98
The Dalles 94
Florence 71
Naples 67
Seoul 66
Shanghai 64
Dallas 60
Sofia 60
Princeton 56
Izmir 55
Bologna 52
Eugene 52
Palermo 51
Catania 47
Jakarta 47
Lauterbourg 47
Salt Lake City 45
São Paulo 45
Moscow 43
Orem 43
Bari 41
Redwood City 40
Buffalo 39
Munich 39
Columbus 34
Bremen 33
Genoa 31
Turin 30
Verona 29
Brussels 28
Tokyo 28
Chennai 27
Frankfurt am Main 27
Cagliari 25
Padova 25
Boardman 24
Phoenix 24
Da Nang 22
Atlanta 21
Montreal 21
Baghdad 20
Mexico City 20
Salerno 20
Guangzhou 19
Mountain View 19
Falls Church 18
Haiphong 18
Tampa 17
Bergamo 16
Boston 16
Parma 16
Pisa 16
Toronto 16
Manchester 15
Reggio Emilia 15
Treviso 15
Warsaw 15
Brescia 14
Des Moines 14
Elk Grove Village 14
Fremont 14
Turku 14
Brooklyn 13
Buenos Aires 13
Dublin 12
Johannesburg 12
Mumbai 12
Venice 12
Cinisello Balsamo 11
Messina 11
Totale 12.140
Nome #
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.817
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial 476
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 428
Analysis of pulmonary sounds for the diagnosis of interstitial lung diseases secondary to rheumatoid arthritis 405
"Velcro-type" crackles predict specific radiologic features of fibrotic interstitial lung disease 400
Clusterin decreases oxidative stress in lung fibroblasts exposed to cigarette smoke 376
Structured reporting for fibrosing lung disease: a model shared by radiologist and pulmonologist 357
Diagnosis of occult tuberculosis in hematological malignancy by enumeration of antigen-specific T cells. 350
Levels of circulating endothelial cells are low in idiopathic pulmonary fibrosis and are further reduced by anti-fibrotic treatments 350
Effectiveness of pulmonary rehabilitation in patients with INTERSTITIAL LUNG DISEASE of different etiology: a multicenter prospective study 345
Detection of Pneumocystis jirovecii and Aspergillus spp. DNa in bronchoalveolar lavage fluids by commercial real-time PCr assays: comparison with conventional diagnostic tests 343
Radiologic classification of usual interstitial pneumonia in rheumatoid arthritis-related interstitial lung disease: correlations with clinical, serological and demographic features of disease 336
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 329
Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors 326
Clinical performance of a commercial real-time PCR assay for Aspergillus DNA detection in serum samples from high-risk patients: comparison with a galactomannan enzyme immunoassay 323
Treatment of chronic obstructive pulmonary disease and its comorbidities 313
Role Of The QFT-IT Assay For The Diagnosis Of Latent Tuberculosis Infection Among Adult Immigrants 312
Complex chronic co-morbidities of COPD 301
Acute exacerbation of idiopathic pulmonary fibrosis: a clinical review 300
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement 297
Prognostic role of clusterin in resected adenocarcinomas of the lung. 296
Pretreatment rate of decay in forced vital capacity predicts long-term response to pirfenidone in patients with idiopathic pulmonary fibrosis. 295
Best supportive care for idiopathic pulmonary fibrosis: Current gaps and future directions 293
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 291
Morbidity and Mortality in Patients with Idiopathic Pulmonary Fibrosis Undergoing Diagnostic Surgical Lung Biopsy 289
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 289
Clusterin (CLU) and lung cancer 288
Acute exacerbations of chronic obstructive pulmonary disease: are antibiotics needed? 286
Mindfulness-based stress reduction in patients with interstitial lung diseases: a pilot, single-centre observational study on safety and efficacy 280
Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis 280
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 278
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 277
Occurrence of idiopathic pulmonary fibrosis during immunosuppressive treatment: a case report 274
Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation 272
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study 269
Management of Idiopathic Pulmonary Fibrosis 267
A Real-Life Multicenter National Study on Nintedanib in Severe Idiopathic Pulmonary Fibrosis 260
Pulmonary comorbidities associated with chronic obstructive pulmonary disease 251
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 250
Pulmonary Carcinosarcoma Arising in the Framework of an Idiopathic Pulmonary Fibrosis 244
INTERSTITIAL LUNG DISEASE IS ASSOCIATED TO INFECTIONS OF LOWER RESPIRATORY TRACT IN IMMUNOCOMPROMISED RHEUMATOID ARTHRITIS PATIENTS 242
AB0472 PRIMARY SJOGREN SYNDROME ASSOCIATED INTERSTITIAL LUNG DISEASE: FEATURES, TREATMENT AND OUTCOME OF A MONOCENTRIC COHORT 241
RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE. RADIOLOGICAL PATTERNS AND CORRELATIONS WITH CLINICAL, SEROLOGICAL AND DEMOGRAPHIC FEATURES OF DISEASE 236
Validation of a Method for Automatic Detection of Lung Sounds in Fibrotic Interstitial Lung Disease 234
Challenges in idiopathic interstitial lung disease 228
Etiology and Level of Lung Derangement Do Not Affect the Beneficial Effect of Pulmonary Rehabilitation in Patients with Interstitial Lung Diseases 220
Co-trimoxazole effect on human alveolar macrophages of AIDS patients 213
CHARACTERIZATION OF ANTI-MPO POSITIVE INTERSTITIAL LUNG DISEASE. CLINICAL-SEROLOGIC AND RADIOLOGIC FEATURES AND SURVIVAL 201
Predictive Value of DLCO Reduction in Scleroderma Patients Without Cardio-Pulmonary Involvement at Baseline 189
High serum levels of silica nanoparticles in systemic sclerosis patients with occupational exposure: Possible pathogenetic role in disease phenotypes 189
Therapeutic approaches to idiopathic pulmonary fibrosis 180
Functional Progression in Patients with Interstitial Lung Disease Resulted Positive to Antisynthetase Antibodies: A Multicenter, Retrospective Analysis 162
Progression and prognosis of interstitial pneumonia with autoimmune features: a longitudinal, prospective, multi-centre study 155
Medicina personalizzata e fibrosi polmonare idiopatica 155
Malattie infiltrative diffuse del polmone 148
Interstitial lung disease and anti-myeloperoxidase antibodies: not a simple association 137
Erratum to: Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement (Clinical Rheumatology, (2017), 36, 6, (1261-1268), 10.1007/s10067-017-3601-1) 136
Pulmonary Progressive Fibrosis in Rheumatoid Arthritis and Primary Sjogren Syndrome: Similarities and Differences 115
Disease progression across the spectrum of idiopathic pulmonary fibrosis: A multicentre study 107
Efectiveness of Nintedanib in Progressive Pulmonary Fibrosis Assessed by Progression Criteria: An Italian, Observational, Multicenter Study 99
Recommendations for radiotherapy in patients with lung cancer and interstitial lung disease: A Delphi consensus process of the Italian association of radiotherapy and clinical oncology (AIRO) 38
Clinical Characteristics of Anti‐Synthetase Syndrome: Analysis From the Classification Criteria for Anti‐Synthetase Syndrome Project 38
Prevalence, incidence and mortality of interstitial lung disease in patients with Sjogren disease: data from the prospective observational “EMERGE” study 37
Impact of Dosing on Functional and Clinical Outcomes of Patients With Progressive Pulmonary Fibrosis Treated With Nintedanib: Data From a Real-World, Multicentric, Italian Study 35
Multidisciplinary management of interstitial lung disease in autoimmune rheumatic diseases: an Italian Delphi consensus 7
Totale 19.755
Categoria #
all - tutte 61.768
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.768


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021487 0 0 0 0 0 0 0 0 0 218 147 122
2021/20221.458 86 116 113 107 62 92 64 84 171 100 260 203
2022/20232.122 193 178 119 181 203 237 123 198 239 112 192 147
2023/20242.061 115 139 156 199 270 224 201 225 60 95 174 203
2024/20253.315 198 112 115 263 593 432 282 211 338 136 270 365
2025/20264.923 345 191 395 599 902 443 771 254 557 466 0 0
Totale 19.755